1 IL-2 is a lymphocyte immunoregulatory hormone that has no direct impact on cancer cells. The administration of IL-2 to cancer patients is based solely on its ability to mediate immune reactions ...

Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

Despite the challenges, there's still plenty of interest in IL-2 as a cancer therapy, with several companies, including Medicenna, Anaveon, Cue Biopharma, Aulos Bioscience, and Synthekine in ...

Immunotherapy is the brightest new weapon in fight against cancer. Thank Dr. Steven Rosenberg, who 40 years ago successfully ...

Researchers from Rice University and Baylor College of Medicine have demonstrated a groundbreaking treatment that eradicates ...

This page includes links to articles highlighting the top skin cancer research published on Cancer Therapy Advisor in 2024.

LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class IL-2 therapeutics, today ...

US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial ...

HELSINKI, Finland, Dec. 05, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing intravenously delivered cancer immunotherapies, announces it will be ...

“We are very encouraged by the translational data for STK-012 monotherapy as it represents a powerful advancement in cancer therapy, designed to realize the full efficacy potential of IL-2 while ...